V43 N8 P 391 Abstract
V43 N8 P 391 Abstract
V43 N8 P 391 Abstract
Original Article
Abstract
Introduction: Erythroderma is a generalised inflammatory reaction of the skin secondary to
a variety of causes. This retrospective study aims to characterise the features of erythroderma
and identify the associated causes of this condition in our population. Materials and Methods:
We reviewed the clinical, laboratory, histological and other disease-specific investigations of 225
inpatients and outpatients with erythroderma over a 7.5-year period between January 2005 and
June 2012. Results: The most common causative factors were underlying dermatoses (68.9%),
idiopathic causes (14.2%), drug reactions (10.7%), and malignancies (4.0%). When drugs and
underlying dermatoses were excluded, malignancy-associated cases constituted 19.6% of the
cases. Fifty-five percent of malignancies were solid-organ malignancies, which is much higher than
those previously reported (0.0% to 25%). Endogenous eczema was the most common dermatoses
(69.0%), while traditional medications (20.8%) and anti-tuberculous medications (16.7%) were
commonly implicated drugs. In patients with cutaneous T-cell lymphoma (CTCL), skin biopsy was
suggestive or diagnostic in all cases. A total of 52.4% of patients with drug-related erythroderma
had eosinophilia on skin biopsy. Electrolyte abnormalities and renal impairment were seen in 26.2%
and 16.9% of patients respectively. Relapse rate at 1-year was 17.8%, with no associated mortality.
Conclusion: Our study highlights the significant proportion of malignancy-related erythroderma
in those whom common underlying causes such as dermatoses and drugs have been excluded. In
cases of drug-related erythroderma, traditional medications and antituberculous medications are
common causes in our population. Renal impairment and electrolyte abnormalities are commonly
seen and should be monitored in patients with erythroderma.
1
National Skin Centre, Singapore
2
Annenberg School for Communication, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Address for Correspondence: Tey Hong Liang, National Skin Centre, 1 Mandalay Road, Singapore 308205.
Email: teyhongliang111@yahoo.com